Yunzhi Dang Selected Research

PF-04136309

1/2021

GOLM1 Drives Colorectal Cancer Metastasis by Regulating Myeloid-derived Suppressor Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunzhi Dang Research Topics

Disease

6	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2020
5	Neoplasms (Cancer) 01/2020 - 12/2012
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2015 - 12/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2018

Drug/Important Bio-Agent (IBA)

3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2020
2	B7-H1 AntigenIBA 02/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 04/2015 - 12/2012
1	Tumor Biomarkers (Tumor Markers)IBA 03/2024
1	AntigensIBA 03/2024
1	squamous cell carcinoma-related antigenIBA 03/2024
1	1- (2- bromophenyl)- 3- (7- cyano- 3H- benzotriazol- 4- yl)ureaIBA 02/2022
1	SB 225002IBA 01/2022
1	PF-04136309IBA 01/2021
1	3-Phosphoinositide-Dependent Protein KinasesIBA 01/2020
1	InterleukinsIBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	BX 471IBA 01/2020
1	vasodilator-stimulated phosphoproteinIBA 01/2020
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	BLU9931IBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Sincalide FDA Link 02/2018
1	LuciferasesIBA 02/2018
1	Cyclin D1IBA 02/2018
1	Hypoxia-Inducible Factor 1IBA 01/2017
1	heparanaseIBA 01/2017
1	ParaffinIBA 12/2012

Therapy/Procedure

1	Therapeutics 01/2022